Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms

Conditions

• Benign Prostatic Hyperplasia
• Lower Urinary Tract Symptoms

Interventions

• DRUG: Placebo tamsulosin hydrochloride OCAS 0.4 mg
• DRUG: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg
• DRUG: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg
• DRUG: tamsulosin hydrochloride OCAS 0.4 mg
• DRUG: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg)
• DRUG: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg)

Sponsor

Astellas Pharma Europe B.V.